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release in experimental arthritis and inhibits neutrophil accumulation in
the inﬂamed joint, thereby revealing anti-inﬂammatory potential. Apart
from these data, little is known about localisation, regulation, signal
transduction and function of melanocortins in cartilage.
Methods: Human articular chondrocytes isolated from OA-cartilage were
proliferated in monolayer until passage one and cultured in 3D-micromass
pellets for either 1 or 7 days. After stimulation for 48 h with 10−6 M a-MSH,
RNA was isolated and the cDNA copy number of Sox9, collagen I, II and
X; MMP-2, -7, -9 and -13; Il-1b, TNF-a and Il-6 was assessed with qRT-
PCR. MC-1R expression was determined by RT-PCR and immunohisto-
chemistry. Signal transduction of a-MSH was evaluated by cAMP ELISA
and Ca2+ assay using Fura2-AM.
Results:We have detected protein and gene expression of the MC-1R in
articular chondrocytes derived from osteoarthritic cartilage. The MC-1R
detected in human chondrocytes appears functional as stimulation with a-
MSH resulted in a moderate but signiﬁcant increase in intracellular cAMP
levels but not in changes of the intracellular Ca2+ level. In vitro application
of a-MSH altered gene expression of collagens, MMPs, cytokines and
Sox9 in a culture time depended pattern in articular chondrocytes. In
general, at an early time point a-MSH induced a downregulation of the
majority of these genes while at a later time point they mostly were
upregulated.
Conclusions: The time-dependent gene expression induction/suppression
pattern indicates a differentiation speciﬁc involvement of a-MSH in pro-
cesses like re-differentiation and endochondral ossiﬁcation as a factor
with possibly trophic functions. The aMSH dependent regulation of cy-
tokines and MMPs points towards a role in modulation of inﬂammatory
or degenerative processes in diseases such as RA and OA.
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Purpose: MMP-28 (epilysin) is a recently discovered member of the ma-
trix metalloproteinase family. We have previously reported expression of
MMP28 in normal human articular cartilage and synovium with signiﬁcant
induction of expression in osteoarthritis. The regulation of the MMP28
gene and the physiological function and substrates of the MMP-28 protein
are currently unknown.
Methods: Expression constructs for wild-type proteinases and inactive
mutants were cloned into pcDNA4-FLAG. Protein expression after trans-
fection into a variety of cell types was assessed by western blotting and
immunocytochemistry. Stable cell lines were generated using SW1353
chondrosarcoma cells and clonal lines were then generated. Functional
analyses included cell proliferation, adhesion and migration. Promoter-
reporter constructs were made in pGL3 and transiently transfected using
FuGene6. DNA-protein interaction was assessed by gel mobility shift
assay. Acetylation of Sp1 and Sp3 was probed using immunoprecipitation
with a speciﬁc antibody and western blot with an anti-(pan acetyl lysine)
antibody.
Results: Lysates from SW1353 cells over-expressing the full-length
MMP28 cDNA contained pro-MMP-28, conditioned medium contained
pro-MMP-28 and a cleaved C-terminal domain, and ECM fractions con-
tained some pro-MMP-28 and also the active form. Using a furin inhibitor,
we found that the activation of MMP-28 was furin dependent. Overex-
pression of MMP-28 leads to increased adhesion on both ﬁbronectin and
type II collagen, though migration and proliferation are not altered. An
increase in MMP-2 expression and activity is also seen.
MMP28 expression is induced by histone deacetylase (HDAC) inhibitors
and this effect is mediatedvia Sp1 at a promoter proximal GT-box. Im-
munoprecipitation experiments have shown that the acetylation of both
Sp1 and Sp3 is increased by HDAC inhibitor treatment, however no
effect on DNA binding was observed. Histone acetyltransferases such
as p300 and P/CAF increased induction of the MMP28 promoter by Sp1.
Knockdown of HDAC1 using siRNA also induces the MMP28 promoter.
Oligonucleotide pulldown and ChIP assays identiﬁed other proteins re-
cruited to the MMP28 promoter including c-Jun and serine threonine
receptor-associated protein (STRAP).
Conclusions: In initial studies to characterise the regulation and function
of MMP-28, we observed that the activation of pro-MMP-28 is furin
dependent. Interestingly, the active enzyme preferentially associates with
the ECM. This may suggest a matrix substrate for MMP-28. We have
successfully generated SW1353 cell lines stably transfected with MMP28
(full length, EA mutant and pro-cat). Phenotypic changes to adhesion
and proliferation have been measured, along with altered expression
of other metalloproteinase genes. A more complete analysis including
candidate protein and proteomic screens of potential substrates is cur-
rently underway. We also present evidence that MMP28 is regulated by
HDAC inhibitors and that this is via alterations in transcription factor
acetylation. Since HDAC inhibitors are known to be chondroprotective,
this is important both to potential function of MMP-28 and the design of
therapeutics which target HDACs.
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Purpose: Non-steroidal anti-inﬂammatory drugs and selective COX-2 in-
hibitors are commonly used for the symptomatic treatment of osteoarthri-
tis (OA). Several conﬂicting reports about the effects of these drugs
on articular cartilage have been reported. VA441 is a novel compound,
strictly related to coxibs, which in vitro proved to be a potent and highly
selective COX-2 inhibitor being equipotent with rofecoxib and in the HWB
test demonstrated to be as selective as valdecoxib. Furthermore, VA441
showed, in vivo, a very good activity against both carrageenan induced
hyperalgesia and carrageenan induced oedema in the rat paw, with a
complete remission 1 hour after the administration. In the abdominal
constriction VA441 was able to reduce the number of writhes in a
statistically signiﬁcant manner.
The aim of the present study was to investigate the in vitro effect of
VA441 in comparison with Indomethacin and Celecoxib on chondrocyte
proliferation and ultrastructure and on some biochemical parameters in
human chondrocyte cultures in presence or in absence of Il-1b.
Methods: Human articular cartilage was obtained from 5 subjects with
OA undergoing surgery for total hip replacement. Chondrocytes were
feeded at 4×104 cells/well. VA441, Indomethacin and Celecoxib were
added at concentration of 0.1, 1 and 10mM with and without Il-1b
(5 ng/mL) for 3 days. Proliferative response of chondrocyte was examined
by a colorimetric assay (MTT). Proteoglycans and MMP-3 release in
the culture medium and Prostaglandin E2 levels were determined by an
ELISA assay. Aggrecan gene expression was evaluated by RT-PCR. Mor-
phological analyses were performed by transmission electron microscopy
(TEM) and scanning electron microscopy (SEM) and at least 100 cells
from each group were evaluated.
Results: In comparison with control cultures, Indomethacin and Cele-
coxib did not change signiﬁcantly chondrocyte proliferation, while VA441
led to a signiﬁcant increase of chondrocyte proliferation. When the cells
are cultured in the presence of Il-1b, VA441 and Celecoxib, a statistically
signiﬁcant restoration of PGs levels is observed, also conﬁrmed by gene
expression of Aggrecan. On the contrary, Indomethacin determined a
signiﬁcant decrease in PGs concentrations in the culture medium.VA441
also induced a signiﬁcant decrement in MMP-3 release, higher than
Indometancin and comparable to that induced by Celecoxib. Furthermore,
VA441 and Celecoxib led to a signiﬁcant reduction in the PGE2 concen-
trations. The results are conﬁrmed by morphological ﬁndings obtained by
TEM and SEM.
Conclusions: This in vitro study shows the beneﬁcial effects of VA441
on chondrocyte metabolism and morphology.
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Purpose: To assess the effects of N-acetylcysteine (NAC), a powerful
antioxidant, on expression or release of different pro-inﬂammatory and
structural mediators in human osteoarthritic (OA) synoviocytes and chon-
drocytes in culture.
Methods: Synoviocytes and chondrocytes were obtained from the knee
synovial membranes or the articular cartilage, respectively, of patients
